2025-523160-20-00招募中1 期
A Phase 1 Study of IM-1021 in Participants with Advanced Cancer
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 23
- 试验地点
- 4
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Development Operations
Scientific
Immunome Inc.
研究点 (4)
Loading locations...
相似试验
尚未招募
不适用
Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic CancerNCT07325214IMGT Co., Ltd.360
尚未招募
2 期
NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + DinutuximabNeuroblastomaNCT07261241New Approaches to Neuroblastoma Therapy Consortium118
招募中
3 期
Study to assess the efficacy and safety of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD)Major Depressive Disorder2024-519421-37-00Neurocrine Biosciences Inc.55
招募中
1 期
Study in Advanced Solid Tumor PatientsNCT07300943Callio Therapeutics306
招募中
1 期
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.2025-522243-17-00Philogen S.p.A.96